| Autor: |
Peterlin P; Clinical Hematology, Nantes University Hospital, Nantes, France; CRCI2NA UMR INSERM 1307CNRS 6075 - Nantes Université - Angers University, Nantes. pierre.peterlin@chu-nantes.fr., Gaschet J; CRCI2NA UMR INSERM 1307CNRS 6075 - Nantes Université - Angers University, Nantes., Turlure P; Clinical Hematology, Limoges University Hospital, Limoges., Gourin MP; Clinical Hematology, Limoges University Hospital, Limoges., Dumas PY; Clinical Hematology, Bordeaux University Hospital Haut-Lévêque, Pessac., Thepot S; Clinical Hematology, Angers University Hospital, Angers., Berceanu A; Clinical Hematology, Besançon University Hospital, Besançon., Park S; Clinical Hematology, Grenoble University Hospital, Grenoble., Hospital MA; Clinical Hematology, Institut Paoli Calmettes, Marseille., Cluzeau T; Clinical Hematology, Nice University Hospital, Nice., Torregrosa-Diaz JM; Clinical Hematology, Poitiers University Hospital, Poitiers., Drevon L; Clinical Hematology, Saint Louis Hospital, Paris., Sapena R; Groupe Francophone des Myélodysplasies, Paris., Chermat F; Groupe Francophone des Myélodysplasies, Paris., Ades L; Clinical Hematology, Saint Louis Hospital, Paris., Dimicoli-Salazar S; Clinical Hematology, Bordeaux University Hospital Haut-Lévêque, Pessac., Jullien M; Clinical Hematology, Nantes University Hospital, Nantes, France; CRCI2NA UMR INSERM 1307CNRS 6075 - Nantes Université - Angers University, Nantes., Fenaux P; Groupe Francophone des Myélodysplasies, Paris., Chevallier P; Clinical Hematology, Nantes University Hospital, Nantes, France; CRCI2NA UMR INSERM 1307CNRS 6075 - Nantes Université - Angers University, Nantes. |
